Related Experiment Video

Updated: May 22, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy

George Bayliss1, Larry A Weinrauch, John A D'Elia

  • 1Division of Kidney Diseases and Hypertension, Rhode Island and Miriam Hospitals, Providence, USA. gbayliss@lifespan.org

Current Diabetes Reports
|May 29, 2012
PubMed

Insights

Obesity-related kidney injury shares mechanisms with diabetic nephropathy, driven by insulin resistance and hyperfiltration. This review explores hormonal and signaling pathways causing these similar renal damage patterns.

Area of Science:

  • Nephrology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Insulin resistance is increasingly linked to obesity-induced renal injury.
  • Obesity can cause hyperfiltration and glomerulomegaly, mimicking diabetic nephropathy.
  • Histologic damage patterns in obesity and diabetes suggest overlapping injury mechanisms.

Purpose of the Study:

  • To review hormonal mechanisms and signaling pathways in obesity-related renal injury.
  • To compare injury patterns in obesity and diabetic nephropathy.
  • To elucidate the reasons for similarities in renal damage between obesity and diabetes.

Main Methods:

  • Literature review of studies on obesity, insulin resistance, and kidney disease.
  • Analysis of hormonal and cellular signaling pathways involved in renal injury.
  • Comparative examination of histologic findings in obesity-related nephropathy and diabetic nephropathy.

Main Results:

  • Insulin resistance plays a key role in obesity-related renal dysfunction.
  • Hyperfiltration and glomerular hypertrophy are common findings in both conditions.
  • Overlapping molecular and cellular pathways contribute to renal damage.

Conclusions:

  • Obesity and diabetes share common pathways leading to renal injury.
  • Understanding these shared mechanisms is crucial for developing targeted therapies.
  • Further research into insulin resistance in obesity is warranted for nephroprotection.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...